← Back to Search

12-16 hour nutrition for Bone Marrow Transplant

N/A
Waitlist Available
Led By Christopher Dandoy
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients >/= 12 months of age undergoing HSCT and receiving a myeloablative preparative regimen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

Study Summary

This study is evaluating whether the timing of meals may impact sleep, metabolism, and overall health in hospitalized children.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of wake episodes
Number of wake episodes
Secondary outcome measures
Cortisol levels
Glucose levels
Hypertension
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CasesExperimental Treatment1 Intervention
Patients randomized to the cases group will receive their nutrition over a period of 12-16 hours, with minimum 8 hours of fasting and maximum 12 hours of fasting. All patients will receive 100% of their daily nutrition.
Group II: ControlsActive Control1 Intervention
Patients randomized to the control group will receive the current standard of care (24-hour continuous nutrition). All patients will receive 100% of their daily nutrition.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
814 Previous Clinical Trials
6,531,560 Total Patients Enrolled
Christopher DandoyPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What outcomes are researchers hoping to achieve with this experiment?

"This experiment, which will last 21 days, seeks to observe the duration of wakefulness in participants. Additionally, weekly triglyceride levels, changes in weight at day +7, +14 and +21 from day 0 as well as 3 times a week morning cortisol levels are being measured as secondary outcomes."

Answered by AI

Is enrollment open for this experiment?

"This clinical trial, initially publicized on May 19th 2020 and last updated in October 14 2022, is not actively seeking participants. However, 45 other trials are currently recruiting patients for their studies."

Answered by AI
~4 spots leftby Mar 2025